Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment

Journal of Clinical Oncology

Volumn 24, Issue 1, 2006, Pages 77-84

  Mandelblatt, Jeanne S ^a   Lawrence, William F ^a   Cullen, Jennifer ^a   Stanton, Annette L ^a   Krupnick, Janice L ^a   Kwan, Lorna ^a   Ganz, Patricia A ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICARE; MULTICENTER STUDY; OCCUPATIONAL THERAPY; PARTIAL MASTECTOMY; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT WITHDRAWAL; BREAST TUMOR; MIDDLE AGED; SURVIVOR; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; MIDDLE AGED; SURVIVORS;

EID: 33644834864     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.2681     Document Type: Article

References (30)

1. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54:8-29, 2004
2. Ries LAG, Eisner MP, Kosary CL, et al: SEER Cancer Statistics Review, 1975-2000. Bethesda, MD, National Cancer Institute, 2003
3. Fireman BH, Quesenberry CP, Somkin CP, et al: Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 18:51-76, 1997
4. Warren JL, Brown ML, Fay MP, et al: Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol 20: 307-316, 2002
5. Lash TL, Silliman RA: Medical surveillance after breast cancer diagnosis. Med Care 39:945-955, 2001
6. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: A multicenter randomized controlled trial. JAMA 271:1587-1592, 1994
7. Smith TJ, Davidson NE, Schapira DV, et al: American Society ef Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080-1082, 1999
8. Schapira MM, McAuliffe TL, Nattinger AB: Underutilization of mammography in older breast cancer survivors. Med Care 38:281-289, 2000
9. Andersen MR, Urban N: The use of mammography by survivors of breast cancer. Am J Public Health 88:1713-1714, 1998
10. Ganz P, Kwan L, Stanton AL, et al: Quality of life at the end of primary treatment of breast cancer: First results from the Moving Beyond Cancer randomized trial. J Natl Cancer Inst 96:376-387, 2004
11. Stanton AL, Ganz PA, Kwan L, et al: Outcomes from the Moving Beyond Cancer psychoeducational randomized, controlled trial with breast cancer patients. J Clin Oncol 23:6009-6018, 2005
12. Stanton AL, Danoff-Burg S, Sworowski LA, et al: Randomized, controlled trial of written emotional expression and benefit-finding in breast cancer patients. J Clin Oncol 20:4160-4168, 2002
13. American Medical Association: Current Procedural Terminology (CPT) Code Book, 2004. Chicago, IL, American Medical Association, 2004
14. Gold MR, Siegel JE, Russell LB, et al: (eds): Cost-Effectiveness in Health and Medicine. New York, NY, Oxford University Press, 1996
15. Agency for Healthcare Research and Quality: HCUPnet: Healthcare Cost and Utilization Project. http://hcup.ahrq.gov/HCUPnet.asp
16. Lawrence WF, Pehskin BN, Liang W, et al: Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol Biomarkers Prev 10:475-481, 2001
17. Agency for Healthcare Research and Quality: Medical Expenditure Panel Survey. http://www .meps.ahrq.gov/
18. Polsky D, Mandelblatt JS, Weeks JC, et al: Economic evaluation of breast cancer treatment: The value of patient choice. J Clin Oncol 21:1139-1146, 2003
19. Nord C, Mykletun A, Thorsen L, et al: Self-reported health and use of services in long-term cancer survivors. Int J Cancer 114:307-316, 2005
20. Oleske DM, Cobleigh MA, Phillips M, et al: Determination of factors associated with hospitalization in breast cancer survivors. Oncol Nurs Forum 31:1081-1088, 2004
21. Graves EJ, Owings MF: Summary: National Hospital Discharge Survey (volume 301). Hyattsville, MD, National Center for Health Statistics, 2004
22. Hewitt M, Rowland JH, Yancik R: Cancer survivors in the United States: Age, health, and disability. J Gerontol A Biol Sci Med Sci 58:82-91, 2003
23. Nattinger AB, Gottlieb MS, Veum J, et al: Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326: 1102-1107, 1992
24. Hadley J, Mitchell J, Mandelblatt J: Medicare fees and small area variations in breast-conserving surgery among elderly women. Med Care Res Rev 58:334-360, 2001
25. Yancik R, Wesley MN, Rues LA, et al: Effect of age and comorbidity in post-menopausal breast cancer patients aged 55 years and older. JAMA 285:885-892, 2001
26. Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104-110, 1994
27. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology, v.1.2006. http:// www.nccn.org/professionals/physician_gls/PDF/ breast.pdf
28. Hewitt M, Greenfield S, Stovall E From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, Institute of Medicine, National Academy Press, 2006
29. Goodwin JS, Hunt WC, Humble CG, et al: Cancer treatment protocols: Who gets chosen? Arch Intern Med 148:2258-2260, 1988
30. Lafata JE, Simpkins J, Schultz L, et al: Routine surveillance care after cancer treatment with curative intent. Med Care 43:592-599, 2005